<div id="readability-page-1"><p>In a report released today, Vijay Kumar from Evercore ISI maintained a Buy rating on Abbott Laboratories, with a price target of <span id="expert-recommendation-target">$138.00</span>.</p><h3>Claim 50% Off TipRanks Premium</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  and maximize your portfolio's potential</li></ul> <p>Kumar covers the Healthcare sector, focusing on stocks such as Intuitive Surgical, Abbott Laboratories, and Agilent. According to TipRanks, Kumar has an average return of <span>3.4%</span> and a 52.40% success rate on recommended stocks. </p> <p>In addition to Evercore ISI, Abbott Laboratories also received a Buy from Bernstein’s Lee Hambright in a report issued today. However, on the same day, TipRanks – xAI reiterated a Hold rating on Abbott Laboratories (NYSE: ABT).</p></div>

ARKG

<p>Evercore ISI analyst Vijay Kumar has reaffirmed a Buy rating for Abbott Laboratories (ABT) with a price target of $138.00. Kumar, who specializes in the Healthcare sector, has an average return of 3.4% and a 52.40% success rate on his stock recommendations. Additionally, Bernstein's Lee Hambright also issued a Buy rating for Abbott, while TipRanks – xAI maintained a Hold rating on the stock.</p>

Tip Ranks

iShares US Pharma

SPDR S&P Health Equip

Health Care Select Sector SPDR

iShares Global Healthcare

iShares US Medical Devices

Ark Genomic Revolution ETF

Abbott Laboratories

Abacus Global

VG Health

Evercore ISI Sticks to Their Buy Rating for Abbott Laboratories (ABT)